Stocksigma LogoStocksigma Logo

Bal Pharma Clarifies Undisclosed Material Information Not Driving Recent Share Price Volatility

Bal Pharma clarified on 10th Sep'26, in response to surveillance inquiries from NSE and BSE, that it holds no undisclosed price-sensitive or material

Bal Pharma Clarifies Undisclosed Material Information Not Driving Recent Share Price Volatility

Bal Pharma Ltd 路 Others (Uncategorized) 路 10 Sept 2026, 11:39 pm

Bal Pharma Clarifies Undisclosed Material Information Not Driving Recent Share Price Volatility Bal Pharma clarified on 10th Sep'26, in response to surveillance inquiries from NSE and BSE, that it holds no undisclosed price-sensitive or material information driving the recent significant movement in its scrip. The company confirmed full compliance with SEBI LODR disclosure norms within stipulated timelines, noting that no pending announcements or reportable events exist. Management emphasized that the share price volatility is purely natural, market-driven, attributable to prevailing market conditions, and completely disconnected from company management.

Original exchange filing (PDF)

More announcements from Bal Pharma Ltd

All Bal Pharma Ltd announcements